Outcome: dropout due to adverse events. Measure: post-intervention. Intervention (milnacipran) compared with (placebo) Participants: 5555. Direction of improvement: lower. Meta-analysis results: Q = 23.45; df = 14; p = 0.05; $I^2$ = 39.06 per cent; $\tau^2$ = 0.07. Regression test for funnel plot asymmetry was significant: 0.7 (CI 0.29 to 1.11) with p = 0.5 and z = 0.68.